Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension-Reference-Cited by-同舟云学术

Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension

Published:2022-09-30 Issue:4 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Lawrie Allan¹²^ORCID,Hamilton Neil³,Wood Steven²⁴,Exposto Fernando⁵,Muzwidzwa Ruvimbo⁵,Raiteri Louise⁵,Beaudet Amélie⁶,Muller Audrey⁶,Sauter Rafael⁶^ORCID,Pillai Nadia⁶,Kiely David G.²³⁷

Affiliation:

1. National Heart and Lung Institute, Imperial College London London UK

2. Insigneo Institute for In‐Silico Medicine University of Sheffield Sheffield UK

3. Sheffield Pulmonary Vascular Disease Unit Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield UK

4. Scientific Computing, Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital Sheffield UK

5. IQVIA London UK

6. Actelion Pharmaceuticals Ltd. Allschwil Switzerland

7. Department of Infection, Immunity and Cardiovascular Disease University of Sheffield Sheffield UK

Funder

Actelion Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12136

Reference44 articles.

1. Statement on Sarcoidosis

2. Sarcoidosis associated pulmonary hypertension: an update

3. Sarcoidosis

4. Pulmonary hypertension complicating pulmonary sarcoidosis

5. Association between sarcoidosis and cardiovascular comorbidity: A systematic review and meta-analysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcoidosis-Associated Pulmonary Hypertension;Journal of Clinical Medicine;2024-04-02

2. USE OF PULMONARY ARTERIAL HYPERTENSION THERAPIES IN PATIENTS WITH SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION;SARCOIDOSIS VASC DIF;2024